Author:
DALCI Kubilay,KEKEÇ Yalçın,PAYDAŞ Semra,ZORLUDEMİR Suzan,ERGİN Melek,TANRIVERDİ Kahraman,SEYDAOĞLU Gülşah,UÇAR Gülsüm
Subject
General Earth and Planetary Sciences,General Environmental Science
Reference17 articles.
1. 1. Ikeda H, Lethe B, Lehmann F. Characterization of an antigennthat is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor. Immunity 1997;6:199-208.
2. 2. Li CM, Guo M,Borczuk A. Gene expression in Wilm’s tumour mimics the earliest committed evre in the metanephric mesenchymal-epithelial transition. AM J Pathol, 2002;160:2181-2190.
3. 3. Paydas S, Tanrıverdi K, Yavuz S, Seydaoğlu G. PRAME mRNA levels in cases with chronic leukemia: clanical importance and review of the literature. Leuk Res, 2007;31:365-9.
4. 4. Paydas S, Tanriverdi K, Yavuz S, Disel U, Baslamisli F, Burgut R. PRAME mRNA levels in cases with acute leukemia: clinical importance and future prospects. J. Hematol. 79; 257-261, 2005.
5. Neumann E,Engelsberg A, Decker J. Heterogeneous expression of the tumour -associated antigens RAGE-1, PRAME, and glycoprotein 75 in human renal cell carcinoma: candidates for T-cell -based immunotherapies? Cancer Res, 2006;58;4090-4095
5. 6. Matsushita M, Yamazaki R, Kawakami Y. Quantitative analysis of PRAME for detection of minimal residual disease in leukaemia. Methods Mol Med, 2004;97:267-275.